Top Biotechnology companies in Germany by Operating Cash Flow

This ranking features the top 24 Biotechnology companies in Germany ranked by Operating Cash Flow, totalling a Operating Cash Flow of USD 15.83 B, for January 15, 2025.
#
Name
Operating Cash Flow
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD 5.93 B
Dec. 31, 2023 USD 116.36 -0.45%

Germany

2
USD 5.65 B
Dec. 31, 2023 USD 20.20 -1.60%

Germany

3
USD 4.18 B
Dec. 31, 2023 USD 145.16 0.75%

Germany

4
USD 588.93 M
Dec. 31, 2023 USD 49.86 0.81%

Germany

5
USD 51.82 M
Dec. 31, 2023 USD 48.95 1.72%

Germany

6
USD 40.22 M
Dec. 31, 2023 USD 8.09 -2.02%

Germany

7
USD 21.44 M
Dec. 31, 2023 USD 29.11 3.16%

Germany

8
USD 20.12 M
Dec. 31, 2023 USD 5.97 -4.48%

Germany

9
USD 19.33 M
Dec. 31, 2023 USD 18.55 -3.93%

Germany

10
USD 10.10 M
Dec. 31, 2023 USD 4.18 0.60%

Germany

11
USD 3.49 M
Dec. 31, 2023 USD 21.54 1.09%

Germany

12
USD -2.98 M
Dec. 31, 2023 USD 42.87 0.60%

Germany

13
USD -3.23 M
Dec. 31, 2023 USD 4.96 -2.24%

Germany

14
USD -4.46 M
Sept. 30, 2023 USD 3.68 1.46%

Germany

15
USD -10.87 M
Dec. 31, 2023 USD 60.50 -1.24%

Germany

16
USD -11.33 M
Dec. 31, 2023 USD 1.49 -0.76%

Germany

17
USD -16.69 M
Dec. 31, 2023 USD 1.09 3.54%

Germany

18
USD -21.94 M
Dec. 31, 2023 USD 5.29 13.28%

Germany

19
USD -23.78 M
Dec. 31, 2023 USD 2.11 3.12%

Germany

20
USD -36.65 M
Nov. 30, 2023 USD 2.61 0.60%

Germany

21
USD -41.74 M
Dec. 31, 2023 USD 2.34 NA

Germany

22
USD -84.12 M
Dec. 31, 2023 USD 1.33 -6.34%

Germany

23
USD -121.71 M
Dec. 31, 2023 USD 1.07 -4.46%

Germany

24
USD -295.68 M
Dec. 31, 2023 USD 3.95 -0.95%

Germany

Frequently Asked Questions
  • Which Biotechnology company in Germany has the highest Operating Cash Flow ?

    The Biotechnology company in Germany with the highest Operating Cash Flow is BioNTech SE (Frankfurt Stock Exchange: 22UA.F) at USD 5.93 B.

  • Which Biotechnology company in Germany has the lowest Operating Cash Flow ?

    The Biotechnology company in Germany with the lowest Operating Cash Flow is CureVac N.V. (Frankfurt Stock Exchange: 5CV.F) at USD -295.68 M.